NCT04224285

Operational Trial of Dayzz App

Completed NA Last updated 22 June 2022

What this trial tests

NA trial testing Dayzz app in Sleep Initiation and Maintenance Disorders in 1,355 participants. Completed in 30 September 2021.

Timeline

12 August 2020

Primary endpoint
27 May 2021

30 September 2021

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	1,355
Start date	12 August 2020
Primary completion	27 May 2021
Estimated completion	30 September 2021
Sites	1 location across United States

Drugs / interventions tested

• Dayzz app

Conditions studied

• Sleep Initiation and Maintenance Disorders — all drugs for Sleep Initiation and Maintenance Disorders →

Sponsor

Brigham and Women's Hospital

Who can join

18 and older, any sex, with Sleep Initiation and Maintenance Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep deficiency is a hidden cost of our 24-7 society, with 70% of Americans admitting that they routinely obtain insufficient sleep, 30% of US workers report sleeping less than 6 hours per night, and it is estimated that 50-70 million individuals have a sleep disorder. Undiagnosed and untreated sleep disorders are associated with poor health outcomes for the individual and generate substantial costs for the employer. Diminished alertness resulting from sleep deficiency or undiagnosed and untreated sleep disorders contributes to absenteeism, presenteeism (diminished work performance at work), health care expenditure, occupational injuries, workplace accidents, and commute-related motor vehicle crashes; all of which result in substantial direct and indirect costs. The investigators have shown that adverse impacts on employees and employers can be mitigated through a sleep health education and sleep disorder screening program which have been implemented in a variety of industries. Further, smartphone apps are becoming popular. Dayzz has created a personalized sleep training app that evaluates sleep issues and offers a holistic sleep improvement solution. It is unique in that the sleep app uses evidence-based, big-data-based algorithms to provide personalized sleep training plans. The sleep solutions are tailored to the individual user and leverages unique motivational strategies and continuous supportive messaging. The investigators hypothesize that the Dayzz app, offering a personalized, scientifically based sleep training plan, might further promote improved health, safety and well-being. This clinical trial will implement the sleep health education and sleep disorders screening program in combination with the Dayzz app.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Evaluating the impact of a sleep health education and a personalised smartphone application on sleep, productivity and healthcare utilisation among employees: results of a randomised clinical trial.
   Robbins R, Weaver MD, Quan SF, Sullivan JP, et al · · 2022 · cited 9× · PMID 36104122 · DOI 10.1136/bmjopen-2022-062121
2. A clinical trial to evaluate the dayzz smartphone app on employee sleep, health, and productivity at a large US employer.
   Robbins R, Weaver MD, Quan SF, Sullivan JP, et al · · 2022 · cited 4× · PMID 34986183 · DOI 10.1371/journal.pone.0260828